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Background
Juvenile Systemic Lupus Erythematosus (SLE) is an
autoimmune disease with variable clinical features. Neu-
rologic and psychiatric symptoms are reported to occur
in 10 to 80 percent of patients either prior to the diag-
nosis of systemic lupus erythematosus, or during the
course of their illness. The neuropsychiatric manifesta-
tions of SLE are varied, and may be classified as primary
neurologic and psyciatric disease (eg, related to direct
involvement of the neuropsychiatric system), and sec-
ondary disease (eg, related to complications of the dis-
ease and its treatment).
Objective
Describe and compare clinical and laboratory features of
two girls with SLE and neurologic manifestation.
Methods
We report 15 and 10 years girls cases with SLE and
similar neurological symptoms, MRI changes, but differ-
rent origin of encephalitis.
Results
First girls neurological symptoms (headache, depress-
sion, irritability) dated at the first onset of lupus. Neu-
ropsychiatric symptoms manifestated, partial seizures
occured. Immunological tests showed a very high titres
of ANA, antidsDNA. The presence of a combination of
anti-cardiolipin/beta2-glycoprotein I antibodies strongly
associated with CNS vasculitis, abnormal MRI. Treat-
ment with antiepileptic drugs, of steroids puls-therapy
with further oral prednisone and intravenous cyclopho-
sphamide were efective in reducing symptoms. Second
girl’s analogous neuropsychiatric manifestaion occured
after one year of lupus treatment with oral prednisone
and after second cyclophosphamide puls, due to second-
ary factor – viral infection (EBV, HSV) with dominated
organic dysfunction of the central nervous system (sei-
zures, tetraplegy, pseudobulbar paralysis). Her antipho-
spholipid antibodies were low, and had no high
association with neurologic symptoms and MRI changes.
Intavenous methylprednisone and further cyclophospha-
mide therapy was ineffective and Rituximab – ac h i -
meric anti-CD20 monoclonal antibody, as anti-viral
tratment - has been used effectivelly. Her lupus-nefritis
disappeared.
Conclusions
Neuropsychiatric disturbance due to CNS lupus must be
a diagnosis of exclusion, especially in immunosuprressed
patients. All other possible causes of neurologic and
psychiatryic symptoms. particularly viral infection must
be considered. Rituximab was effective in treatment of
Epstein-Bar encephalitis and improved symptoms of
severe SLE.
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